Long-Term Follow-up of Persons Inadvertently Inoculated with SV40 as Neonates
- 17 December 1981
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 305 (25), 1517-1518
- https://doi.org/10.1056/nejm198112173052507
Abstract
SIMIAN virus 40 (SV40) is a papovavirus that is latent in rhesus-monkey kidneys used for tissue culture of poliovirus. SV40 was present in vaccines administered to millions of people and was later found to be oncogenic in laboratory animals, notably newborn hamsters, and capable of transforming human cells in vitro. However, studies of large groups of people inoculated with SV40-contaminated vaccines have yielded no evidence of oncogenicity in human beings, despite continued concern.1 , 2 We studied mortality from cancer in 1073 children who were born between 1960 and 1962 and who, as newborn infants, received monovalent oral poliovirus vaccine or inactivated . . .Keywords
This publication has 11 references indexed in Scilit:
- Expression of SV 40-related T-antigen in cell cultures of human meningiomasThe Science of Nature, 1979
- Screening of human brain tumors for SV40‐related T antigenInternational Journal of Cancer, 1978
- HUMAN EXPOSURE TO SV40: REVIEW AND COMMENT12American Journal of Epidemiology, 1976
- Immunization During Pregnancy Against Poliomyelitis and Influenza in Relation to Childhood MalignancyInternational Journal of Epidemiology, 1973
- EVIDENCE FOR AN SV40-RELATED PAPOVAVIRUS INFECTION OF MANAmerican Journal of Epidemiology, 1972
- Simian Virus 40 in Polio Vaccine: Follow-Up of Newborn RecipientsScience, 1970
- ÆTIOLOGY OF CHILDHOOD LEUKÆMIAThe Lancet, 1965
- An Evaluation of the Carcinogenicity of Simian Virus 40 in ManJAMA, 1963
- Sabin Type I (LSc2ab) Oral Poliomyelitis VaccineAmerican Journal of Diseases of Children, 1962
- Clinical and Serologic Responses in Volunteers Given Vacuolating Virus (SV40) by Respiratory RouteExperimental Biology and Medicine, 1961